HIGHLIGHTS
- who: Sadia Nasir and colleagues from the Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Campus, Islamabad, Pakistan have published the research work: Glioblastoma Multiforme: Probing Solutions to Systemic Toxicity towards High-Dose Chemotherapy and Inflammatory Influence in Resistance against Temozolomide, in the Journal: Pharmaceutics 2023, 687 of /2023/
- what: This study discusses the systemic toxicity of TMZ when administered alone and with lipid-based nanocarriers. The aim of this study was to inspect the role of these downstream genes in TMZresistant GBM cells . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.